DePuy Synthes expands portfolio with nerve assessment platform: 4 things to know

DePuy Synthes, a Johnson & Johnson company, launched Sentio MMG, a digital mechanomyography platform designed to assess nerve status.

Advertisement

Here are four things to know:

1. The platform is also designed to identify and avoid peripheral nerves during spine surgery. It can be used during non-fusion procedures as well as minimally invasive and open spinal fusion operations.

2. Sentio MMG features a touchscreen tablet, control unit, probes and smart sensors that minimizes staff in the operating room.

3. The patented, smart sensor technology provides surgeons with real-time feedback on nerve location through visual and audible alerts.

4. DePuy Synthes is introducing the technology at the North American Spine Society Annual Meeting in Los Angeles, Sept. 26-29.

More articles on devices and implants:
Gramercy Extremity Orthopedics earns variable angle locking technology patent: 3 insights
1st FDA-cleared nanotextured PEEK spinal implant may improve outcomes
How active hinge tables can lead to better spine surgery outcomes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.